BALANCED AT(1) AND AT(2) ANGIOTENSIN-II ANTAGONISTS .2. POTENT 5-ALPHA-HYDROXYACID IMIDAZOLYL BIPHENYL SULFONYLUREAS

被引：8

作者：

DEPREZ, P ^{[1
]}

GUILLAUME, J ^{[1
]}

CORBIER, A ^{[1
]}

FORTIN, M ^{[1
]}

VEVERT, JP ^{[1
]}

HECKMANN, B ^{[1
]}

机构：

[1] ROUSSEL UCLAF,F-93235 ROMAINVILLE,FRANCE

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1995年 / 5卷 / 22期

关键词：

D O I：

10.1016/0960-894X(95)00479-D

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Introduction of an alpha-hydroxyacid moiety in position 5 of the imidazole ring within the imidazolyl biphenyl sulfonyl urea series significantly increased AT(2) binding. Structure activity relationship around this moiety is described and gave rise to balanced AII inhibitors with nanomolar affinity on both AT(1) and AT(2) receptors and with an AT(2)/AT(1) ratio of between 0.4 and 3.

引用

页码：2611 / 2616

页数：6

共 18 条

[1] TRIAZOLINONE BIPHENYLSULFONAMIDE DERIVATIVES AS ORALLY-ACTIVE ANGIOTENSIN-II ANTAGONISTS WITH POTENT AT(1) RECEPTOR AFFINITY AND ENHANCED AT(2) AFFINITY
ASHTON, WT
CHANG, LL
FLANAGAN, KL
HUTCHINS, SM
NAYLOR, EM
CHAKRAVARTY, PK
PATCHETT, AA
GREENLEE, WJ
CHEN, TB
FAUST, KA
CHANG, RSL
LOTTI, VJ
ZINGARO, GJ
SCHORN, TW
SIEGL, PKS
KIVLIGHN, SD
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (17) : 2808 - 2824
[2] ASHTON WT, 1994, EXPERT OPIN INV DRUG, V3, P1105
[3] BUHLMAYER P, 1992, CURR OPIN THER PAT, V2, P1693
[4] NOMENCLATURE FOR ANGIOTENSIN RECEPTORS - A REPORT OF THE NOMENCLATURE-COMMITTEE OF THE COUNCIL-FOR-HIGH-BLOOD-PRESSURE-RESEARCH
BUMPUS, FM
CATT, KJ
CHIU, AT
DEGASPARO, M
GOODFRIEND, T
HUSAIN, A
PEACH, MJ
TAYLOR, DG
TIMMERMANS, PBMWM
[J]. HYPERTENSION, 1991, 17 (05) : 720 - 721
[5] ORAL-ADMINISTRATION OF DUP-753, A SPECIFIC ANGIOTENSIN-II RECEPTOR ANTAGONIST, TO NORMAL-MALE VOLUNTEERS - INHIBITION OF PRESSOR-RESPONSE TO EXOGENOUS ANGIOTENSIN-I AND ANGIOTENSIN-II
CHRISTEN, Y
WAEBER, B
NUSSBERGER, J
PORCHET, M
BORLAND, RM
LEE, RJ
MAGGON, K
SHUM, L
TIMMERMANS, PBMWM
BRUNNER, HR
[J]. CIRCULATION, 1991, 83 (04) : 1333 - 1342
[6] SULFONYLUREAS AND SULFONYLCARBAMATES AS NEW NON-TETRAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - DISCOVERY OF A HIGHLY POTENT ORALLY-ACTIVE (IMIDAZOLYLBIPHENYLYL) SULFONYLUREA (HR-720)
DEPREZ, P
GUILLAUME, J
BECKER, R
CORBIER, A
DIDIERLAURENT, S
FORTIN, M
FRECHET, D
HAMON, G
HECKMANN, B
HEITSCH, H
KLEEMANN, HW
VEVERT, JP
VINCENT, JC
WAGNER, A
ZHANG, JD
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (13) : 2357 - 2377
[7] DEPREZ P, IN PRESS BIOORG ME 1
[8] DEVELOPMENT OF ANGIOTENSIN-II ANTAGONISTS WITH EQUIPOTENT AFFINITY FOR HUMAN AT(1) AND AT(2) RECEPTOR SUBTYPES
GLINKA, TW
DELASZLO, SE
SIEGL, PKS
CHANG, RS
KIVLIGHN, SD
SCHORN, TS
FAUST, KA
CHEN, TB
ZINGARO, GJ
LOTTI, VJ
GREENLEE, WJ
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (19) : 2337 - 2342
[9] EFFECTS OF LOSARTAN ON BLOOD-PRESSURE, PLASMA-RENIN ACTIVITY, AND ANGIOTENSIN-II IN VOLUNTEERS
GOLDBERG, MR
TANAKA, W
BARCHOWSKY, A
BRADSTREET, TE
MCCREA, J
LO, MW
MCWILLIAMS, EJ
BJORNSSON, TD
[J]. HYPERTENSION, 1993, 21 (05) : 704 - 713
[10] HODGES JC, 1994, EXPERT OPIN THER PAT, V4, P1325

← 1 2 →